(Q40121901)

17 September 2017

Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma (English)

1 reference

17 September 2017

G-Y Chau

1

1 reference

17 September 2017

A F-Y Lee

2

1 reference

17 September 2017

S-H Tsay

3

1 reference

17 September 2017

Y-R Ke

4

1 reference

17 September 2017

H-L Kao

5

1 reference

17 September 2017

F-H Wong

6

1 reference

17 September 2017

A-P Tsou

7

1 reference

17 September 2017

Y-P Chau

8

1 reference

17 September 2017

8 June 2007

1 reference

17 September 2017

1 reference

17 September 2017

51

1 reference

17 September 2017

2

1 reference

17 September 2017

204-218

1 reference

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

17 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Identification of a novel splice variant of the human anti-apoptopsis gene survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Influence of survivin and caspase-3 on cell apoptosis and prognosis in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Current approaches to the diagnosis and management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Spectrum and significance of microscopic vascular invasion in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Survivin promotes cell proliferation in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

An evolutionary perspective on apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Inhibition of interleukin 1 beta-converting enzyme-mediated apoptosis of mammalian cells by baculovirus IAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Survivin splice variants regulate the balance between proliferation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Differential subcellular localization of functionally divergent survivin splice variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Expression of IAPs and alternative splice variants in hepatocellular carcinoma tissues and cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Survivin study: what is the next wave?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

Cellular localisation of Survivin: impact on the prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02738.X

10.1111/J.1365-2559.2007.02738.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference